O’Leary, J. G., Gebel, H. M., Ruiz, R. M., Bray, R. A., Marr, J. D., Susskind, B. M., … Klintmalm, G. B. (2012). Preformed MHC Class II Antibodies Increase the Risk of Liver but Not Kidney Rejection after Simultaneous Liver-Kidney Transplant. In LIVER TRANSPLANTATION (Vol. 18, pp. S92–S92).

O’Leary, Jacqueline G., Howard M. Gebel, Richard M. Ruiz, Robert A. Bray, John D. Marr, Brian M. Susskind, Allan D. Kirk, and Goran B. Klintmalm. “Preformed MHC Class II Antibodies Increase the Risk of Liver but Not Kidney Rejection after Simultaneous Liver-Kidney Transplant.” In LIVER TRANSPLANTATION, 18:S92–S92, 2012.

O’Leary JG, Gebel HM, Ruiz RM, Bray RA, Marr JD, Susskind BM, et al. Preformed MHC Class II Antibodies Increase the Risk of Liver but Not Kidney Rejection after Simultaneous Liver-Kidney Transplant. In: LIVER TRANSPLANTATION. 2012. p. S92–S92.

O’Leary, Jacqueline G., et al. “Preformed MHC Class II Antibodies Increase the Risk of Liver but Not Kidney Rejection after Simultaneous Liver-Kidney Transplant.” LIVER TRANSPLANTATION, vol. 18, 2012, pp. S92–S92.

O’Leary JG, Gebel HM, Ruiz RM, Bray RA, Marr JD, Susskind BM, Kirk AD, Klintmalm GB. Preformed MHC Class II Antibodies Increase the Risk of Liver but Not Kidney Rejection after Simultaneous Liver-Kidney Transplant. LIVER TRANSPLANTATION. 2012. p. S92–S92.